Mitochondrial neurogastrointestinal encephalomyopathy
MONDO:0017575A syndrome characterized by the association of gastrointestinal dysmotility, peripheral neuropathy, chronic progressive external ophthalmoplegia and leukoencephalopathy.
Also known as: MNGIE, Mitochondrial Neurogastrointestinal Encephalopathy, Mitochondrial neurogastrointestinal encephalopathy, mitochondrial Neurogastrointestingal encephalopathy, MNGIE syndrome, OGIMD, POLIP, mitochondrial neurogastrointestinal encephalopathy syndrome
26 clinical trials for this condition and its sub-types, 4 tagged with Mitochondrial neurogastrointestinal encephalomyopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Mitochondrial neurogastrointestinal encephalomyopathy
-
Worldwide data pool could pave the way for mitochondrial disease trials
Knowledge-focused Recruiting nowThis study creates a global registry for people with mitochondrial disorders—rare diseases that affect energy production in cells. By collecting health data from 6,000 participants worldwide, researchers aim to understand how these diseases progress and identify the best ways to …
Sponsor: LMU Klinikum • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC
-
MNGIE patients needed to map disease course and speed up future treatments
Knowledge-focused Recruiting nowThis study gathers medical information from people with MNGIE, a rare genetic disease that affects the nerves and digestive system. Researchers want to learn how the disease progresses and find better ways to measure it. Up to 50 patients worldwide can join, and no new treatments…
Sponsor: University of Cambridge • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC